Calcineurin-nuclear factor of activated T cells (CN-NFAT) inhibitors are widely clinically used drugs for immunosuppression, but besides their required T cell response inhibition, they also undesirably affect innate immune cells. Disruption of innate immune cell function can explain the observed susceptibility of CN-NFAT inhibitor-treated patients to opportunistic fungal infections. Neutrophils play an essential role in innate immunity as a defense against pathogens; however, the effect of CN-NFAT inhibitors on neutrophil function was poorly described. Thus, we tested the response of human neutrophils to opportunistic fungal pathogens, namely Candida albicans and Aspergillus fumigatus, in the presence of CN-NFAT inhibitors. Here, we report that the NFAT pathway members were expressed in neutrophils and mediated part of the neutrophil response to pathogens. Upon pathogen exposure, neutrophils underwent profound transcriptomic changes with subsequent production of effector molecules. Importantly, genes and proteins involved in the regulation of the immune response and chemotaxis, including the chemokines CCL2, CCL3, and CCL4 were significantly upregulated. The presence of CN-NFAT inhibitors attenuated the expression of these chemokines and impaired the ability of neutrophils to chemoattract other immune cells. Our results amend knowledge about the impact of CN-NFAT inhibition in human neutrophils.

• Klíčová slova
• NFAT, aspergillus, candida, chemokines, neutrophils,
• MeSH
• Aspergillus fumigatus imunologie   MeSH
• Candida albicans imunologie   MeSH
• chemotaxe MeSH
• kalcineurin * metabolismus   MeSH
• lidé MeSH
• mykózy imunologie   MeSH
• neutrofily * imunologie   metabolismus   MeSH
• signální transdukce * MeSH
• transkripční faktory NFATC * metabolismus   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• kalcineurin * MeSH
• transkripční faktory NFATC * MeSH

Neutrophils are innate immune cells with important roles in antimicrobial defense. However, impaired or dysregulated neutrophil function can result in host tissue damage, loss of homeostasis, hyperinflammation or pathological immunosuppression. A central link between neutrophil activation and immune outcomes is emerging to be the calcineurin-nuclear factor of activated T cells (NFAT) signaling pathway, which is activated by neutrophil detection of a microbial threat via pattern recognition receptors and results in inflammatory cytokine production. This potent pro-inflammatory pathway is also the target of several immunosuppressive drugs used for the treatment of autoimmune disorders, during solid organ and hematopoietic cell transplantations, and as a part of anti-cancer therapy: but what effects these drugs have on neutrophil function, and their broader consequences for immune homeostasis and microbial defense are not yet known. Here, we bring together the emerging literature describing pathology- and drug- induced neutrophil impairment, with particular focus on their effects on calcineurin-NFAT signaling in the innate immune compartment.

• Klíčová slova
• NFAT signaling, calcineurin inbibitors, immunosuppression, neutrophil (PMN) function, pattern recognition receptor (PRR), sepsis,
• MeSH
• cytokiny imunologie   metabolismus   MeSH
• homeostáza imunologie   MeSH
• imunologická tolerance imunologie   MeSH
• kalcineurin imunologie   metabolismus   MeSH
• lidé MeSH
• mediátory zánětu imunologie   metabolismus   MeSH
• neutrofily imunologie   metabolismus   MeSH
• přirozená imunita imunologie   MeSH
• receptory rozpoznávající vzory imunologie   metabolismus   MeSH
• signální transdukce imunologie   MeSH
• transkripční faktory NFATC imunologie   metabolismus   MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• přehledy MeSH
• Názvy látek
• cytokiny MeSH
• kalcineurin MeSH
• mediátory zánětu MeSH
• receptory rozpoznávající vzory MeSH
• transkripční faktory NFATC MeSH

Calcineurin (CN) inhibitors are effective clinical immunosuppressants but leave patients vulnerable to potentially fatal fungal infections. This study tested the hypothesis that CN inhibition interferes with antifungal immune defenses mediated by monocytes. We showed that NFAT is expressed by human monocytes, and is activated by exposure to fungal ligands. We confirmed that NFAT translocation potently activated target gene transcription using a human monocytic reporter cell line. Inhibition of CN-NFAT by cyclosporine A significantly reduced monocyte production of TNF-α, IL-10, and MCP-1 proteins in response to pattern recognition receptor ligands as well as to Aspergillus fumigatus conidia. Moreover, we revealed that human monocytes express the antifungal protein pentraxin-3 under control of NFAT. In conclusion, clinical CN inhibitors have the potential to interfere with the novel NFAT-dependent pentraxin-3 pathway as well as antifungal cytokine production in human monocytes, thereby impeding monocyte-mediated defenses against fungal infection in immune-suppressed patients.

• Klíčová slova
• Tacrolimus, antifungal response, cyclosporine A, pattern recognition receptor signaling,
• MeSH
• antifungální látky metabolismus   MeSH
• Aspergillus fumigatus účinky léků   MeSH
• C-reaktivní protein metabolismus   MeSH
• chemokiny metabolismus   MeSH
• cyklosporin farmakologie   MeSH
• inhibitory kalcineurinu farmakologie   MeSH
• interleukin-10 metabolismus   MeSH
• lidé MeSH
• monocyty účinky léků   metabolismus   MeSH
• myeloidní buňky účinky léků   metabolismus   MeSH
• myši MeSH
• sekvence nukleotidů MeSH
• sekvenční homologie aminokyselin MeSH
• sérový amyloidový protein metabolismus   MeSH
• signální transdukce účinky léků   MeSH
• THP-1 buňky MeSH
• TNF-alfa metabolismus   MeSH
• transkripční faktory NFATC metabolismus   MeSH
• transport proteinů účinky léků   MeSH
• vazebná místa MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• antifungální látky MeSH
• C-reaktivní protein MeSH
• chemokiny MeSH
• cyklosporin MeSH
• inhibitory kalcineurinu MeSH
• interleukin-10 MeSH
• PTX3 protein MeSH Prohlížeč
• sérový amyloidový protein MeSH
• TNF-alfa MeSH
• transkripční faktory NFATC MeSH

Diffuse large B-cell lymphoma (DLBCL) represents the most common adult lymphoma and can be divided into 2 major molecular subtypes: the germinal center B-cell-like and the aggressive activated B-cell-like (ABC) DLBCL. Previous studies suggested that chronic B-cell receptor signaling and increased NF-κB activation contribute to ABC DLBCL survival. Here we show that the activity of the transcription factor NFAT is chronically elevated in both DLBCL subtypes. Surprisingly, NFAT activation is independent of B-cell receptor signaling, but mediated by an increased calcium flux and calcineurin-mediated dephosphorylation of NFAT. Intriguingly, although NFAT is activated in both DLBCL subtypes, long-term calcineurin inhibition with cyclosporin A or FK506, both clinically approved drugs, triggers potent cytotoxicity specifically in ABC DLBCL cells. The antitumor effects of calcineurin inhibitors are associated with the reduced expression of c-Jun, interleukin-6, and interleukin-10, which were identified as NFAT target genes that are particularly important for the survival of ABC DLBCL. Furthermore, calcineurin blockade synergized with BCL-2 and MCL-1 inhibitors in killing ABC DLBCL cells. Collectively, these findings identify constitutive NFAT signaling as a crucial functional driver of ABC DLBCL and highlight calcineurin inhibition as a novel strategy for the treatment of this aggressive lymphoma subtype.

• MeSH
• difúzní velkobuněčný B-lymfom farmakoterapie   metabolismus   patologie   MeSH
• inhibitory kalcineurinu farmakologie   MeSH
• kalcineurin chemie   MeSH
• lidé MeSH
• nádorové buňky kultivované MeSH
• proliferace buněk MeSH
• protein MCL-1 genetika   metabolismus   MeSH
• protoonkogenní proteiny c-bcl-2 genetika   metabolismus   MeSH
• transkripční faktory NFATC antagonisté a inhibitory   metabolismus   MeSH
• vápník metabolismus   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• inhibitory kalcineurinu MeSH
• kalcineurin MeSH
• MCL1 protein, human MeSH Prohlížeč
• protein MCL-1 MeSH
• protoonkogenní proteiny c-bcl-2 MeSH
• transkripční faktory NFATC MeSH
• vápník MeSH

The Parkinson's disease-associated protein, Leucine-rich repeat kinase 2 (LRRK2), a known negative regulator of nuclear factor of activated T cells (NFAT), is expressed in myeloid cells such as macrophages and dendritic cells (DCs) and is involved in the host immune response against pathogens. Since, the Ca2+/NFAT/IL-2 axis has been previously found to regulate DC response to the fungus Aspergillus, we have investigated the role played by the kinase LRRK2 during fungal infection. Mechanistically, we found that in the early stages of the non-canonical autophagic response of DCs to the germinated spores of Aspergillus, LRRK2 undergoes progressive degradation and regulates NFAT translocation from the cytoplasm to the nucleus. Our results shed new light on the complexity of the Ca2+/NFAT/IL-2 pathway, where LRRK2 plays a role in controlling the immune response of DCs to Aspergillus.

• Klíčová slova
• Aspergillus, NRON, autophagy, dendritic cell, leucine-rich repeat kinase 2, nuclear factor of activated T cells,
• MeSH
• Aspergillus imunologie   MeSH
• aspergilóza imunologie   mikrobiologie   MeSH
• autofagie imunologie   MeSH
• časosběrné zobrazování MeSH
• dendritické buňky imunologie   ultrastruktura   MeSH
• genový knockdown MeSH
• interakce hostitele a parazita imunologie   MeSH
• interleukin-2 metabolismus   MeSH
• intravitální mikroskopie MeSH
• kationty dvojmocné metabolismus   MeSH
• kultivované buňky MeSH
• lidé MeSH
• LRRK2 genetika   imunologie   metabolismus   MeSH
• malá interferující RNA metabolismus   MeSH
• modely nemocí na zvířatech MeSH
• myši inbrední C57BL MeSH
• myši MeSH
• proteolýza MeSH
• RNA dlouhá nekódující genetika   imunologie   metabolismus   MeSH
• signální transdukce imunologie   MeSH
• spory hub imunologie   MeSH
• transkripční faktory NFATC metabolismus   MeSH
• transmisní elektronová mikroskopie MeSH
• vápník metabolismus   MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• myši MeSH
• zvířata MeSH
• Publikační typ
• audiovizuální média MeSH
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• interleukin-2 MeSH
• kationty dvojmocné MeSH
• Lrrk2 protein, mouse MeSH Prohlížeč
• LRRK2 MeSH
• malá interferující RNA MeSH
• NRON long non-coding RNA, mouse MeSH Prohlížeč
• RNA dlouhá nekódující MeSH
• transkripční faktory NFATC MeSH
• vápník MeSH

Myeloid leucocytes mediate host protection against infection and critically regulate inflammatory responses in body tissues. Pattern recognition receptor signalling is crucial for myeloid cell responses to pathogens, but growing evidence suggests an equally potent role for Calcineurin-NFAT signalling in control of myeloid cell function. All major subsets of myeloid leucocytes employ Calcineurin-NFAT signalling during immune responses to pathogens and/or tissue damage, but the influence this pathway exerts on pathogen clearance and host susceptibility to infection is not fully understood. Recent data from experimental models indicate that Calcineurin-NFAT signalling is essential for infection control, and calcineurin inhibitors used in transplantation medicine (including cyclosporine A and tacrolimus) are now being tested for efficacy in a diverse range of inflammatory conditions and autoimmune pathologies. Efforts to repurpose calcineurin inhibitor drugs for new therapeutic applications may yield rapid improvements in clinical outcomes, but the potential impact of these compounds on myeloid cell function in treated patients is largely unknown. Here we discuss Calcineurin-NFAT control of myeloid leucocyte function in the context of recent therapeutic developments and ongoing clinical studies.

• Klíčová slova
• Dectin‐1, TLR4, cyclosporine A, immunosuppression, tacrolimus,
• MeSH
• imunosupresiva terapeutické užití   MeSH
• kalcineurin metabolismus   MeSH
• leukocyty imunologie   MeSH
• lidé MeSH
• signální transdukce * MeSH
• transkripční faktory NFATC metabolismus   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• přehledy MeSH
• Názvy látek
• imunosupresiva MeSH
• kalcineurin MeSH
• transkripční faktory NFATC MeSH

Th17 cells express diverse functional programs while retaining their Th17 identity, in some cases exhibiting a stem-cell-like phenotype. Whereas the importance of Th17 cell regulation in autoimmune and infectious diseases is firmly established, the signaling pathways controlling their plasticity are undefined. Using a mouse model of invasive pulmonary aspergillosis, we found that lung CD103(+) dendritic cells (DCs) would produce IL-2, dependent on NFAT signaling, leading to an optimally protective Th17 response. The absence of IL-2 in DCs caused unrestrained production of IL-23 and fatal hyperinflammation, which was characterized by strong Th17 polarization and the emergence of a Th17 stem-cell-like population. Although several cell types may be affected by deficient IL-2 production in DCs, our findings identify the balance between IL-2 and IL-23 productions by lung DCs as an important regulator of the local inflammatory response to infection.

• MeSH
• alfa řetězce integrinu imunologie   MeSH
• Aspergillus imunologie   MeSH
• aspergilóza imunologie   patologie   MeSH
• buněčná diferenciace MeSH
• buňky Th17 imunologie   MeSH
• CD antigeny imunologie   MeSH
• dendritické buňky imunologie   MeSH
• interleukin-2 biosyntéza   imunologie   MeSH
• kalcineurin metabolismus   MeSH
• myši inbrední C57BL MeSH
• myši transgenní MeSH
• myši MeSH
• plíce imunologie   mikrobiologie   patologie   MeSH
• transkripční faktory NFATC metabolismus   MeSH
• vápník metabolismus   MeSH
• zvířata MeSH
• Check Tag
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• alfa řetězce integrinu MeSH
• alpha E integrins MeSH Prohlížeč
• CD antigeny MeSH
• interleukin-2 MeSH
• kalcineurin MeSH
• transkripční faktory NFATC MeSH
• vápník MeSH

Death receptor-6 (DR6) apparently participates in the regulation of T-cell activation and/or activity as its genetic disruption results in enhanced CD4+ T-cell expansion, the production of Th2 cytokines, and interestingly also the compromised migration of CD4+ T cells to sites of inflammation. However, the mechanism of regulation of DR6 expression in cells of the immune system is not fully understood. In this communication we show that DR6 is not expressed in resting T cells from human peripheral blood or murine lymph nodes but that its expression is significantly upregulated in CD3 crosslinking- or PMA/ionomycin-activated T lymphocytes. DR6 expression is transiently increased in both activated human CD4+ and CD8+ T cells and it is apparently dependent on the activation of NF-κB and NF-AT signaling pathways. In contrast to primary peripheral blood T cells, the widely used model lymphoblastic leukemia T-cell line Jurkat is DR6-positive and unexpectedly, TCR-mediated stimulation of Jurkat cells strongly downregulates DR6 expression via suppression of its transcription.

• MeSH
• aktivace lymfocytů * MeSH
• antigeny CD3 imunologie   MeSH
• CD4-pozitivní T-lymfocyty imunologie   metabolismus   MeSH
• CD8-pozitivní T-lymfocyty imunologie   metabolismus   MeSH
• interleukiny biosyntéza   MeSH
• Jurkat buňky MeSH
• lidé MeSH
• myši transgenní MeSH
• myši MeSH
• NF-kappa B metabolismus   MeSH
• pohyb buněk MeSH
• polymerázová řetězová reakce MeSH
• promotorové oblasti (genetika) MeSH
• receptory antigenů T-buněk metabolismus   MeSH
• receptory TNF genetika   MeSH
• signální transdukce MeSH
• Th2 buňky imunologie   metabolismus   MeSH
• transkripční faktory NFATC metabolismus   MeSH
• upregulace MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• antigeny CD3 MeSH
• interleukiny MeSH
• NF-kappa B MeSH
• receptory antigenů T-buněk MeSH
• receptory TNF MeSH
• Tnfrsf21 protein, mouse MeSH Prohlížeč
• transkripční faktory NFATC MeSH

INTRODUCTION: Breast cancer is one of the most common types of cancer in women. One of the genes that were found mutated in breast cancer is casein kinase 1 epsilon (CK1epsilon). Because CK1epsilon is a crucial regulator of the Wnt signaling cascades, we determined how these CK1epsilon mutations interfere with the Wnt pathway and affect the behavior of epithelial breast cancer cell lines. METHODS: We performed in silico modeling of various mutations and analyzed the kinase activity of the CK1epsilon mutants both in vitro and in vivo. Furthermore, we used reporter and small GTPase assays to identify how mutation of CK1epsilon affects different branches of the Wnt signaling pathway. Based on these results, we employed cell adhesion and cell migration assays in MCF7 cells to demonstrate a crucial role for CK1epsilon in these processes. RESULTS: In silico modeling and in vivo data showed that autophosphorylation at Thr 44, a site adjacent to the breast cancer point mutations in the N-terminal lobe of human CK1epsilon, is involved in positive regulation of the CK1epsilon activity. Our data further demonstrate that, in mammalian cells, mutated forms of CK1epsilon failed to affect the intracellular localization and phosphorylation of Dvl2; we were able to demonstrate that CK1epsilon mutants were unable to enhance Dvl-induced TCF/LEF-mediated transcription, that CK1epsilon mutants acted as loss-of-function in the Wnt/beta-catenin pathway, and that CK1epsilon mutants activated the noncanonical Wnt/Rac-1 and NFAT pathways, similar to pharmacological inhibitors of CK1. In line with these findings, inhibition of CK1 promoted cell migration as well as decreased cell adhesion and E-cadherin expression in the breast cancer-derived cell line MCF7. CONCLUSIONS: In summary, these data suggest that the mutations of CK1epsilon found in breast cancer can suppress Wnt/beta-catenin as well as promote the Wnt/Rac-1/JNK and Wnt/NFAT pathways, thus contributing to breast cancer development via effects on cell adhesion and migration. In terms of molecular mechanism, our data indicate that the breast cancer point mutations in the N-terminal lobe of CK1epsilon, which are correlated with decreased phosphorylation activities of mutated forms of CK1epsilon both in vitro and in vivo, interfere with positive autophosphorylation at Thr 44.

• MeSH
• beta-katenin metabolismus   MeSH
• buněčná adheze MeSH
• duktální karcinom prsu genetika   metabolismus   patologie   MeSH
• fosforylace MeSH
• imunoprecipitace MeSH
• kaseinkinasa Iepsilon chemie   genetika   metabolismus   MeSH
• konformace proteinů MeSH
• lidé MeSH
• MAP kinasa-kinasa 4 metabolismus   MeSH
• messenger RNA genetika   MeSH
• mutace genetika   MeSH
• nádorové buněčné linie MeSH
• nádory prsu genetika   metabolismus   patologie   MeSH
• pohyb buněk * MeSH
• polymerázová řetězová reakce s reverzní transkripcí MeSH
• proliferace buněk MeSH
• proteiny Wnt metabolismus   MeSH
• rac1 protein vázající GTP metabolismus   MeSH
• transkripční faktory NFATC metabolismus   MeSH
• western blotting MeSH
• Check Tag
• lidé MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Research Support, N.I.H., Extramural MeSH
• Názvy látek
• beta-katenin MeSH
• kaseinkinasa Iepsilon MeSH
• MAP kinasa-kinasa 4 MeSH
• messenger RNA MeSH
• proteiny Wnt MeSH
• rac1 protein vázající GTP MeSH
• RAC1 protein, human MeSH Prohlížeč
• transkripční faktory NFATC MeSH